<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR48">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Burmester</surname>
    <given-names>GR</given-names>
   </name>
   <name>
    <surname>Panaccione</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Gordon</surname>
    <given-names>KB</given-names>
   </name>
   <name>
    <surname>McIlraith</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Lacerda</surname>
    <given-names>AP</given-names>
   </name>
  </person-group>
  <article-title>Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease</article-title>
  <source>Ann Rheum Dis</source>
  <year>2013</year>
  <volume>72</volume>
  <fpage>517</fpage>
  <lpage>524</lpage>
  <pub-id pub-id-type="doi">10.1136/annrheumdis-2011-201244</pub-id>
  <?supplied-pmid 22562972?>
  <pub-id pub-id-type="pmid">22562972</pub-id>
 </element-citation>
</ref>
